FDA Clears Emerging Cable-Free, AI-Powered C-Arm System

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Allia Moveo C-arm platform, which may facilitate increased maneuverability for procedures involving interventional radiologists.

GE HealthCare, the manufacturer of the Allia Moveo device, said the compact cable-free C-arm system allows for ease of use and quick positioning adjustments.

The Allia Moveo system also has artificial intelligence (AI) features, including CleaRecon DL, Motion Freeze, and Metallic Artifact Reduction, that remove streak artifacts from pulsatile blood flow in the arteries, reduce respiratory motion artifacts and reveal key anatomic details that can be obscured by metal artifacts.

“One of the major milestones of this new system is having access to the reconstruction of the cone beam CT with CleaRecon DL, which is AI driven and gives you much better image quality,” noted Stephan Haulon, M.D., Ph.D., the head of the aortic center and vascular surgery at the Hopital Marie-Lannelongue in Paris.

“This innovative platform enhances how our clinicians navigate complex minimally invasive procedures by improving mobility, image clarity, and workflow efficiency. It strengthens our ability to deliver precise, patient-centered care while supporting our teams with technology designed for the evolving demands of modern interventional medicine,” added Brad Lembke, M.D., the president of Baylor St. Luke’s Medical Center in Houston.